Humana Inc. (NYSE:HUM) has a beta of 0.87, a 12-month trailing P/E ratio of 15.98, and a growth ratio of 1.21. The stock’s Relative Strength Index (RSI) is 53.31, with weekly volatility at 1.44% and ATR at 8.57. The HUM stock’s 52-week price range has touched low of $365.06 and a $475.44 high. Its shares traded lower over the last trading session, losing -0.22% on 05/18/21. The shares fell to a low of $444.41 before closing at $449.46. Intraday shares traded counted 1.21 million, which was -36.93% lower than its 30-day average trading volume of 880.23K. HUM’s previous close was $450.46 while the outstanding shares total 128.93M.
Investors have identified the Healthcare Plans company Humana Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $58.40 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Humana Inc. (HUM) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. For HUM, the company has in raw cash 3.88 billion on their books with 1.2 billion currently as liabilities. How the trend is over time is what investors should be concerned about. The company has a healthy balance sheet as their debt profile has been on an incline. In terms of their assets, the company currently has 25.53 billion total, with 15.3 billion as their total liabilities.
Having a look at the company’s valuation, the company is expected to record 24.51 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on HUM sounds very interesting.
Is the stock of HUM attractive?
In related news, Seg Pres, Clin & Phm Solutions, Fleming William Kevin sold 8,899 shares of the company’s stock in a transaction that recorded on May 04. The sale was performed at an average price of 459.29, for a total value of 4,087,205. As the sale deal closes, the Segment President, Retail, Wheatley Timothy Alan now sold 8,508 shares of the company’s stock, valued at 3,833,609. Also, Seg Pres. Gr. & Military Bus., HUNTER CHRISTOPHER H. sold 5,156 shares of the company’s stock in a deal that was recorded on Apr 29. The shares were price at an average price of 443.76 per share, with a total market value of 2,288,046. Following this completion of acquisition, the Chief Administrative Officer, Huval Timothy S. now holds 3,871 shares of the company’s stock, valued at 1,716,900. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.10%.
16 out of 24 analysts covering the stock have rated it a Buy, while 8 have maintained a Hold recommendation on Humana Inc.. 0 analysts has assigned a Sell rating on the HUM stock. The 12-month mean consensus price target for the company’s shares has been set at $486.89.